Hyperfine (NASDAQ:HYPR – Get Free Report) and Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.
Insider & Institutional Ownership
15.0% of Hyperfine shares are owned by institutional investors. 29.4% of Hyperfine shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
This is a breakdown of current ratings for Hyperfine and Pheton Holdings Ltd Class A Ordinary Shares, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Hyperfine | 0 | 1 | 0 | 0 | 2.00 |
Pheton Holdings Ltd Class A Ordinary Shares | 0 | 0 | 0 | 0 | 0.00 |
Valuation and Earnings
This table compares Hyperfine and Pheton Holdings Ltd Class A Ordinary Shares”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Hyperfine | $13.26 million | 5.33 | -$44.24 million | ($0.57) | -1.70 |
Pheton Holdings Ltd Class A Ordinary Shares | $572,291.00 | 44.28 | N/A | N/A | N/A |
Pheton Holdings Ltd Class A Ordinary Shares has lower revenue, but higher earnings than Hyperfine.
Profitability
This table compares Hyperfine and Pheton Holdings Ltd Class A Ordinary Shares’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Hyperfine | -309.42% | -57.54% | -50.38% |
Pheton Holdings Ltd Class A Ordinary Shares | N/A | N/A | N/A |
Summary
Hyperfine beats Pheton Holdings Ltd Class A Ordinary Shares on 5 of the 9 factors compared between the two stocks.
About Hyperfine
Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.
About Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.